XML 26 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings Per Share
9 Months Ended
Sep. 30, 2017
Earnings Per Share [Abstract]  
Earnings Per Share
EARNINGS PER SHARE

The computations of basic and diluted earnings per share follow:
 
 
For the Three Months Ended September 30,
 
 
2017
 
2016
Dollars in thousands,
except per share amounts
 
Income
(Numerator)
 
Common
Shares
(Denominator)
 
Per
Share
 
Income
(Numerator)
 
Common
Shares
(Denominator)
 
Per
Share
Net income
 
$
5,930

 
 
 
 
 
$
4,281

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic earnings per share
 
$
5,930

 
12,299,987

 
$
0.48

 
$
4,281

 
10,692,423

 
$
0.40

 
 
 
 
 
 
 
 
 
 
 
 
 
Effect of dilutive securities:
 
 
 
 
 
 

 
 
 
 
 
 

Stock options
 
 
 
10,911

 
 

 
 
 
12,865

 
 

Stock appreciation rights (SARs)
 
 
 
8,061

 
 
 
 
 
21,851

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diluted earnings per share
 
$
5,930

 
12,318,959

 
$
0.48

 
$
4,281

 
10,727,139

 
$
0.40


 
 
For the Nine Months Ended September 30,
 
 
2017
 
2016
Dollars in thousands,
except per share amounts
 
Income
(Numerator)
 
Common
Shares
(Denominator)
 
Per
Share
 
Income
(Numerator)
 
Common
Shares
(Denominator)
 
Per
Share
Net income
 
$
9,592

 
 
 
 
 
$
12,586

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic earnings per share
 
$
9,592

 
11,781,342

 
$
0.81

 
$
12,586

 
10,682,129

 
$
1.18

 
 
 
 
 
 
 
 
 
 
 
 
 
Effect of dilutive securities:
 
 

 
 
 
 

 
 
 
 
 
 

Stock options
 
 
 
11,336

 
 

 
 
 
8,774

 
 

Stock appreciation rights (SARs)
 
 
 
14,324

 
 
 
 
 
1,443

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diluted earnings per share
 
$
9,592

 
11,807,002

 
$
0.81

 
$
12,586

 
10,692,346

 
$
1.18


Stock option and stock appreciation right (SAR) grants are disregarded in this computation if they are determined to be anti-dilutive.  Our anti-dilutive stock options for the quarter and nine months ended September 30, 2017 were 23,400 shares, and totaled 33,600 for the three months ended September 30, 2016 and 57,000 for the nine months ended September 30, 2016. Our anti-dilutive SARs for three and nine months ended September 30, 2017 were 87,615.